The capacity of our nationwide clinical team, means we’re conducting clinical review services or clinical audits on a daily basis, working with practices to review their use of medicines, optimise patient care, and investigate disease prevalence in pre-determined therapy areas.
All clinical review services have been expertly created by our service design team, and provides on-site support for clinicians, practice staff, and when requested, directly to patients. ICS deliver clinical reviews in a range of therapy areas, including stroke prevention in atrial fibrillation (AF), osteoporosis, diabetes, asthma and chronic obstructive pulmonary disease (COPD), to name just a few. And we’re continually working with practices to create new reviews and services to meet the needs of the locality.
As well as being designed to ensure effective care for patients, the ICS clinical review services are created to consider the Quality Outcomes Framework (QOF) and look to increase practice prevalence where applicable, complementing our QOF Enhancement Service.
Whilst ICS work with practices at a local level to deliver clinical reviews, we also act as an independent partner with CCGS, health boards, GP federations and industry to offer sponsored or joint working opportunities where available, creating cost and clinical efficiencies for practices and clinicians.